PT  - JOURNAL ARTICLE
AU  - Tomoyuki Ohe
AU  - Tadahiko Mashino
AU  - Masaaki Hirobe
TI  - Substituent Elimination From<em>p</em>-Substituted Phenols by Cytochrome P450
DP  - 1997 Jan 01
TA  - Drug Metabolism and Disposition
PG  - 116--122
VI  - 25
IP  - 1
4099  - http://dmd.aspetjournals.org/content/25/1/116.short
4100  - http://dmd.aspetjournals.org/content/25/1/116.full
SO  - Drug Metab Dispos1997 Jan 01; 25
AB  - When various p-substituted phenols (substituent = NO2, CN, CH2OH, COCH3, COPh, COOH, F, Cl, and Br) were incubated with rat liver microsomes, the substituent was eliminated to produce hydroquinone, and the reaction was inhibited by CO and a cytochrome P450-specific inhibitor. In the case of p-cresol (substituent = CH3),p-toluquinol was formed instead of hydroquinone. Experiments using 18O2 proved that the elimination is accompanied with ipso-substitution by the oxygen atom of the active species in cytochrome P450. These results are similar to those in a cytochrome P450 chemical model system (Ohe, T.,et al., Tetrahedron Lett. 42, 7681–7684, 1995), implying that the model is a good mimic of cytochrome P450. Substrates that lack a hydroxy group, namely p-substituted toluenes, did not undergo the reaction, thus indicating that a hydroxy group at the p-position to the eliminated substituent is necessary for this pathway. This is the same as the result obtained with the cytochrome P450 model. Finally, to elucidate how the substituent is eliminated, we attempted to detect the product derived from the eliminated group with several substrates. Results indicated that the mechanism of the substituent elimination can be divided into two types: the substituent is eliminated as an anion or as a cation. The American Society for Pharmacology and Experimental Therapeutics